Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 25%
Buy 75%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy is well-positioned to continue its strong financial performance, with estimated revenue growth of 7% and 5% in 2026 and 2027, respectively. The company has a diverse mix of payment sources, including managed care programs, commercial health insurance, Medicare/Medicaid, and workers' compensation insurance, which ensures stability and a steady stream of revenue. Furthermore, recent results have shown positive trends in key metrics, such as an increase in same-store visits and improved net revenue per patient visit. The company's strategic partnerships with hospital systems also provide potential for significant growth and value creation in the future. While patient and wage pressures may impact profitability, US Physical Therapy's strong financial management, as evidenced by its positive EBITDA and gross margins, positions it well to overcome these challenges and continue delivering solid performance.

Bears say

US Physical Therapy is experiencing mixed results for its Q1, with revenue exceeding expectations but profitability lower than analysts projected. While the company is showing growth in its industrial injury prevention segment, its total operating costs have also increased. Additionally, the recent hospital system partnerships may provide potential upside in the future, but this factor is not yet reflected in the company's valuation. With a lower price target due to sector multiple compression, analysts remain optimistic about the company's growth potential and believe the risk-reward profile is favorable for investors.

USPH has been analyzed by 4 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 75% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 4 analysts, USPH has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $98.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $98.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.